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ROMK1 channels are located in the apical membrane of the
connecting tubule and cortical collecting duct and mediate
the potassium secretion during normal dietary intake.
We used a perforated whole-cell patch clamp to explore the
effect of angiotensin II on these channels in HEK293 cells
transfected with green fluorescent protein (GFP)-ROMK1.
Angiotensin II inhibited ROMK1 channels in a dose-
dependent manner, an effect abolished by losartan or by
inhibition of protein kinase C. Furthermore, angiotensin II
stimulated a protein kinase C-sensitive phosphorylation of
tyrosine 416 within c-Src. Inhibition of protein tyrosine kinase
attenuated the effect of angiotensin II. Western blot studies
suggested that angiotensin II inhibited ROMK1 channels by
enhancing its tyrosine phosphorylation, a notion supported
by angiotensin II’s failure to inhibit potassium channels in
cells transfected with the ROMK1 tyrosine mutant (R1Y337A).
However, angiotensin II restored the with-no-lysine kinase-4
(WNK4)-induced inhibition of R1Y337A in the presence of
serum–glucocorticoids-induced kinase 1 (SGK1), which
reversed the inhibitory effect of WNK4 on ROMK1. Moreover,
protein tyrosine kinase inhibition abolished the angiotensin
II-induced restoration of WNK4-mediated inhibition of
ROMK1. Angiotensin II inhibited ROMK channels in the
cortical collecting duct of rats on a low sodium diet, an effect
blocked by protein tyrosine kinase inhibition. Thus,
angiotensin II inhibits ROMK channels by two mechanisms:
increasing tyrosine phosphorylation of the channel and
synergizing the WNK4-induced inhibition. Hence,
angiotensin II may have an important role in suppressing
potassium secretion during volume depletion.
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ROMK1 channels are located in the apical membrane of the
connecting tubule and the cortical collecting duct (CCD) and
have an important role in mediating K secretion under
normal dietary K intake.1–3 Our previous study has demon-
strated that Src-family protein tyrosine kinase (PTK) is
involved in increasing inhibition of ROMK1 channels during
K restriction.3 The effect of PTK on ROMK1 channels is at
least partially the result of increasing tyrosine phosphory-
lation of ROMK1 channels on tyrosine residue 337.4,5
Consequently, tyrosine-phosphorylated ROMK1 channels
are subjected to endocytosis.6 In addition, ROMK1 channels
are also inhibited by with-no-lysine kinase (WNK) family
kinases including WNK1, WNK3, and WNK4.7–10 It has been
demonstrated that WNK1 and WNK4 stimulate the inter-
nalization of ROMK channels by a mechanism involving
intersection, a scaffolding protein, and clathrin.10 Recently,
we have reported that Src-family PTK is also involved in
modulating the interaction between serum–glucocorticoids-
induced kinase 1 (SGK1) and WNK4 by diminishing the
SGK1-mediated phosphorylation of WNK4.11 Consequently,
SGK1 failed to reverse the inhibitory effect of WNK4 on
ROMK channels in the presence of Src-family PTK. However,
the physiological factor that stimulates Src-family PTK is not
known. Our previous study has demonstrated that stimula-
tion of angiotensin II (AngII) type I receptor (AT1R)
inhibited ROMK channel activity through a PTK-dependent
pathways in the native CCD of rats on a low K diet.12
Moreover, AngII has been shown to stimulate Src-family PTK
in vascular tissue.13 Therefore, we speculate that AngII may
be one of the upstream factors that stimulate Src-family PTK
and modulate the effect of SGK1 on WNK4 under physio-
logical conditions. Hence, the goal of this study is to test
whether AngII also inhibits ROMK channels by enhancing the
inhibitory effect of WNK4 on ROMK1 channels and to test
whether AngII decreases ROMK channels in the native CCD.
RESULTS
We used HEK293T cells transfected with green fluorescent
protein (GFP)-ROMK1 to study the effect of AngII on
ROMK channels. Figure 1a is a typical western blot carried
out with lysates from HEK293T cells and rat kidney (cortex)
and demonstrates the expression of endogenous AT1R in
HEK 293T cells. We measured Ba2þ -sensitive K currents with
the perforated whole-cell recording technique under control
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conditions and in the cells treated with AngII (100 nM) for
20 min. Figure 1b is a whole-cell patch recording showing
that K currents in cells transfected with GFP-ROMK1 were
inward rectified and that application of AngII (100 nM)
inhibited ROMK1 channels. We also measured the cell
capacitances, which varied between 24.5 and 26 pF. The value
was used to normalize the K currents to that of a cell with
25 pF capacitance. The effect of AngII on ROMK channels
was dose dependent: application of 50, 100, and 200 nM
AngII decreased K currents from 1086±35 pA (n¼ 6) to
833±30 pA (n¼ 6), 678±30 pA (n¼ 6), and 527±22 pA
(n¼ 6), respectively (Figure 1c). The effect of AngII on
ROMK channels was the result of stimulation of AT1R
because losartan completely abolished the inhibitory effect of
AngII on the ROMK channels (Figure 1b). Data summarized
in Figure 1c show that losartan (20 mM) per se has no
significant effect on K currents (1127±50 pA, n¼ 6) in
comparison with the control value. However, 100 nM AngII
failed to decrease K currents (1120±52 pA, n¼ 6) in the
presence of losartan.
After demonstrating that stimulation of AT1R inhibited
ROMK channels, we examined the effect of AngII (100 nM)
on ROMK1 channels in HEK293T cells pretreated with
protein kinase C (PKC) inhibitors, calphostin C (100 nM), for
20 min. Although inhibition of PKC had no significant effect
on ROMK channel activity, it abolished the effect of AngII.
As calphostin C may have an effect other than inhibiting
PKC, we repeated the experiments with GF109203x (5mM).
Data summarized in Figure 2 show that treatment of
HEK293T cells transfected with ROMK1 with either calpho-
stin C (100 nM) or GF109203x (5 mM) abolished the inhibitory
effect of AngII on ROMK channels (control, 1090±40 pA;
calphostin CþAngII, 1110±40 pA. GF109203xþAngII,
1100±40 pA). Thus, the present results are in consistence
with experiments performed in the rat CCD, in which
inhibition of PKC blocked the effect of AngII on ROMK
channels.12 In that study the effect of AngII was also
suppressed by blocking PTK.12 To examine the role of PTK
in mediating the effect of AngII on ROMK channels, we
studied whether AngII increases tyrosine phosphorylation
of c-Src on tyrosine residue 416, an indication of activated
c-Src, which was used as a representative member of
Src-family PTK. Figure 3a is a typical western blot from five
experiments demonstrating that application of AngII at 5, 10,
25, 50, and 100 nM within 30 min enhanced the tyrosine
phosphorylation of c-Src on the residue 416, whereas
AngII did not change the total c-Src expression. Also,
inhibition of PKC with calphostin C (100 nM) attenuated the
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Figure 1 |Angiotensin II (AngII) inhibits ROMK1 channels. (a) A western blot showing the expression of type 1 Ang II receptor (AT1R) in
HEK293T cells and the rat kidney. (b) Whole-cell Ba2þ -sensitive K currents in HEK293T cells transfected with green fluorescent protein
(GFP)-ROMK1 in the absence of AngII (control) and in the presence of 100 nM AngII and AngIIþ losartan (20 mM), respectively. K currents were
measured with the perforated whole-cell patch clamp from 100 to 60mV at a step of 20mV. (c) A bar graph summarizes the inhibitory
effect of AngII on ROMK1 channels at different concentrations in the absence of or presence of losartan (20 mM). K currents were
measured with perforated whole-cell patch clamp at 100mV in HEK293T cells transfected with GFP-ROMK1. I (pA), currents (pA).
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AngII-induced stimulation of tyrosine phosphorylation of
c-Src on tyrosine residue 416 (n¼ 3; Figure 3b), suggesting
that AngII stimulates Src-family PTK by a PKC-dependent
mechanism. Because ROMK1 channel is the substrate of
Src-family PTK, increasing Src-family PTK activity by AngII
is expected to stimulate tyrosine phosphorylation of ROMK1
channels. Therefore, we examined the effect of AngII on
the tyrosine phosphorylation of ROMK1 channels in the
HEK293T cells treated with AngII (100 nM) for 30 min.
ROMK1 proteins were harvested by immunoprecipitation
with anti-GFP antibodies and tyrosine phosphorylation of
ROMK1 was detected by PY20, which reacts with tyrosine-
phosphorylated proteins. Figure 3c is a western blot showing
that AngII increased ROMK1 tyrosine phosphorylation. In
contrast, the effect of AngII on ROMK tyrosine phospho-
rylation is absent in cells transfected with R1Y337A
(Figure 3d). The notion that AngII-induced inhibition of
ROMK1 channels was, at least partially, the result of
enhancing tyrosine phosphorylation of ROMK1 channels
was further tested by examining the effect of AngII on
ROMK1 channels in the presence of herbimycin A. Figure 4a
is a whole-cell channel recording showing that coexpression
of c-Src or application of AngII decreased K currents
measured with the perforated whole-cell recording technique
and that inhibition of PTK with herbimycin A completely
abolished the effect of c-Src and AngII on ROMK1 channels.
Coexpression of c-Src enhanced c-Src expression is
demonstrated in Figure 4b. Figure 4c summarizes the results
from five experiments showing that AngII decreased K
currents from 1090±40 to 675±30 pA, whereas c-Src
expression reduced K currents from 1100±40 to
530±32 pA. In contrast, neither AngII nor c-Src expression
decreased K currents in cells treated with herbimycin A
(AngIIþ herbimycin A, 1300±50 pA; c-Srcþ herbimycin A,
1350±45 pA). The effect of AngII on ROMK1 channel is
possibly mediated through stimulating phosphorylation of
ROMK1 in tyrosine 337 because AngII failed to inhibit
ROMK1 mutant, R1Y337A in which the tyrosine residue 337
was mutated (Figure 4d). Similar results were obtained with
small interfering RNA (siRNA) of c-Src and Figure 5a is a
whole-cell recording demonstrating the effect of down-
regulation of c-Src on ROMK1 channels. To downregulate
endogenous c-Src, we used two c-Src siRNAs, siRNA832 and
siRNA1430, which target nucleotide sequence 832 and 1430 of
c-Src, respectively. Figure 5b is a western blot demonstrating
the expression of c-Src in HEK293T cells treated with two
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Figure 2 | Inhibition of protein kinase C abolishes the
inhibitory effect of angiotensin II (AngII). A bar graph
summarizes the effect of AngII on ROMK1 channels in the absence
of or in the presence of calphostin C (100 nM) or GF109203x (5 mM).
HEK293T cells transfected with green fluorescent protein-ROMK1
were pretreated with calphostin C or GF109203x. The K currents
were measured with the perforated whole-cell recording at
100mV. Asterisk (*) indicates a significant difference from the
control value.
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Figure 3 |Angiotensin II (AngII) stimulates c-Src
phosphorylation and tyrosine phosphorylation of ROMK1.
(a) A western blot showing that treatment of HEK293T cells with
AngII for 20–30min increases the tyrosine phosphorylation of
c-Src on tyrosine residue 416. (b) A western blot demonstrating
the effect of AngII on tyrosine phosphorylation of c-Src on
tyrosine 416 in the HEK293T cells pretreated with calphostin C.
A western blot shows the effect of AngII (100 nM) on the tyrosine
phosphorylation of ROMK1 in cells transfected with green
fluorescent protein (GFP-ROMK1) (c) or with GFP-R1Y337A (d).
ROMK1 proteins were harvested by immunoprecipitation with
anti-GFP antibodies and tyrosine phosphorylation of ROMK1 was
detected with PY20.
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kinds of c-Src-siRNA. It is apparent that both c-Src siRNAs
specifically downregulate c-Src by 80±15% (n¼ 4) but failed
to change the expression of PKCe, AT1R, and actin. Data
summarized in Figure 5c demonstrate that suppression of
endogenous c-Src expression significantly increased K
currents in cells transfected with ROMK1 from 1080±40
to 1615±40 pA (siRNA832, n¼ 5) or 1557±30 pA (siR-
NA1430, n¼ 5), suggesting that ROMK1 channels were
suppressed by endogenous c-Src. Moreover, AngII failed to
inhibit ROMK channels in HEK293T cells treated with c-Src
siRNA (1600±40 pA for siRNA832, 1516±30 pA for siR-
NA1430). Hence, these results support the role of c-Src in
mediating the effect of AngII on ROMK1 channels.
PTK decreases ROMK channel activity not only by
increasing tyrosine phosphorylation of ROMK channels but
also by inhibiting the stimulatory effect of SGK1 on WNK4.11
Therefore, it is possible that AngII may also inhibit ROMK
channels by modulating the effect of SGK1 on WNK4 thereby
enhancing WNK4-induced inhibition. This hypothesis was
tested by examining whether AngII synergizes the inhibitory
effect of WNK4 by reversing the effect of SGK1 on WNK4.
We used the perforated whole-cell patch recording to
measure the K currents in HEK293T cells transfected with
GFP-R1Y337A, a ROMK1 mutant in which a tyrosine
phosphorylation site was mutated to alanine. The advantage
of using R1Y337A for the study is that AngII had no effect
on ROMK1 channels, thereby making the interpretation
straightforward. Figure 6a is a set of whole-cell patch
recordings illustrating the K currents under different
experimental conditions. Data summarized in Figure 6b
shows that the expression of SGK1 not only significantly
increased K currents in cells transfected with GFP-ROM-
K1Y337A from 1700±50 to 2570±90 pA (n¼ 6) but also
abolished the inhibitory effect of WNK4 on ROMK channels:
SGK1 increased K currents in cells transfected with
WNK4þGFP-ROMK1Y337A from 830±30 pA (n¼ 6) to
1734±70 pA (n¼ 6), a value not different from the control.
Also, 100 nM AngII alone had no effect on ROMK1Y337A
in cells transfected with SGK1þROMK1Y337A. However,
in cells transfected with ROMK1Y337AþWNK4þ SGK1,
100 nM AngII decreased K currents from 1734±70 to
950±30 pA (n¼ 6), a value not significantly different from
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Figure 4 | Inhibition of protein tyrosine kinase abolishes the effect of Angiotensin II (AngII). (a) The whole-cell recording demonstrates
the effect of c-Src and AngII treatment on K currents in HEK293T cells transfected with green fluorescent protein-ROMK1 with or
without herbimycin A. (b) A western blot showing the expression of c-Src in HEK293T cells transfected with or without exogenous c-Src.
(c) A bar graph summarizes the effect of c-Src expression or 100 nM AngII treatment on ROMK1 channels in the presence of herbimycin A
(1 mM). (d) Effect of AngII (100 nM) on K currents in HEK cells transfected with R1Y337A. The K currents were measured with perforated
whole-cell patch recording at 100mV. Asterisk (*) indicates a significant difference from the control value.
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those with WNK4 (830±30 pA), and significantly lower than
those with WNK4þ SGK1 (1730±70 pA). The role of c-Src
in mediating the effect of AngII was indicated by the
observation that herbimycin A (1 mM) abolished the effect of
AngII in cells transfected with WNK4þ SGK1þROM-
K1Y337A. The results, therefore, strongly indicate that AngII
inhibited ROMK1 channels also by abolishing the effect of
SGK1–WNK4 interaction.
The mechanism by which AngII inhibits ROMK channels
in the presence of SGK1 may have a role in suppressing K
secretion during volume depletion, which is known to
stimulate aldosterone and SGK1 activity. Therefore, we used
the patch clamp experiment to examine the effect of AngII
on ROMK channels in the CCD of rats on a low Na diet to
demonstrate the physiological relevance of the present
finding. We confirmed the previous report that ROMK
channel activity in rats on a low Na diet was not significantly
different from those on a control diet.14 Moreover, applica-
tion of 50 nM AngII decreased ROMK channel activity from
1.1±0.1 to 0.1±0.05 (n¼ 4; Figure 7a). Figure 7b is a
channel recording showing that AngII (50 nM) inhibited
ROMK channels in the CCD of rats on a low Na diet. We
then examined the effect of AngII on ROMK in the CCD
treated with herbimycin A. Although herbimycin A also
inhibits heat shock protein, HSP90, and is not a specific c-Src
blocker,15 Herbimycin A stimulated ROMK only in the
animals on a K-deficient diet but not on a high K (HK) diet,
which has a low c-Src activity.16 This suggests that the effect
of herbimycin A on ROMK channels was relatively specific
and the result of inhibiting src-family PTK under our
experimental conditions. Figure 7a summarizes the results of
four experiments showing that treatment of the CCD with
1 mM herbimycin A for 20 min not only significantly increased
channel activity (NPo, 2.0±0.3) but also abolished the effect
of AngII on ROMK channels (NPo, 2.05±0.3). This suggests
that AngII inhibited ROMK in the CCD through a PTK-
dependent mechanism.
DISCUSSION
The main finding of this study is that AngII inhibited ROMK
channels by a Src-family PTK-dependent pathway. The role
of Src-family PTK in mediating the effect of AngII is
supported by two lines of evidence: (1) AngII stimulates
tyrosine phosphorylation of c-Src at tyrosine residue 416; (2)
inhibition of PTK with herbimycin A or downregulation of
c-Src with siRNA abolishes the effect of AngII on ROMK
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Figure 5 |Downregulation of endogenous c-Src abolishes the effect of angiotensin II (AngII). (a) The whole-cell recording
demonstrates the effect of downregulating c-Src with small interfering RNA (siRNA), increasing K currents and abolishing the effect of
AngII on ROMK1 channels in HEK293T cells transfected with green fluorescent protein-ROMK1. (b) A western blot showing the effect
of c-Src siRNA on the expression of c-Src, protein kinase Ce (PKCe), AngII type I receptor (AT1R), and actin in HEK293T cells. (c) A bar
graph summarizes the effect of siRNA of c-Src on AngII-induced inhibition of ROMK1 channels. The K currents were measured with
perforated whole-cell patch recording at 100mV. ‘#’ Indicates significance from rest of groups.
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channels. Therefore, the present results are consistent with
the previous study performed in the rat CCD, in which AngII
inhibited ROMK channels by a PTK-dependent mechan-
ism.12 Moreover, this experiments strongly suggests that
Src-family PTK inhibits ROMK channels not only by
stimulating tyrosine phosphorylation of ROMK channels
but also by abolishing the effect of SGK1–WNK4 interaction
on ROMK channels. Our previous studies have shown
that ROMK1 channels were phosphorylated by Src-family
PTK on tyrosine residue 337 and that increase in tyrosine
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phosphorylation of ROMK1 channels facilitated the endo-
cytosis.5,6 The observation that AngII increased the tyrosine
phosphorylation of ROMK strongly supports the notion that
the inhibitory effect of AngII on ROMK1 channels is, at least
partially, the result of increasing tyrosine phosphorylation.
Relevant to the second possibility that AngII affects
SGK1–WNK4 interaction is the finding that AngII restored
the inhibitory effect of WNK4 on K channels in the presence
of SGK1 in cells transfected with R1Y337A, which was not
sensitive to either AngII or c-Src in the absence of WNK4.11
This suggests that AngII enhances WNK4-induced inhibition
of ROMK channels by suppressing the effect of SGK1 on
WNK4. However, the effect of AngII in regulating ROMK
channels in vivo has only been demonstrated in severe
K-restricted animals and may not have a major role in
inhibiting ROMK channels under control conditions.12 Also,
the concentrations used in this experiments were higher than
physiological concentrations. Moreover, it has been reported
that AngII has a biphasic effect on bicarbonate transport in
the proximal tubules.17 Because the sensitivity of AT1R to
AngII may be different between native tissue and cultured
cells, the aim of this experiments is to prove the principal that
AngII has a role in modulating the effect of WNK4–SGK1
interaction on ROMK channels.
WNK4 is expressed in the aldosterone-sensitive distal
nephron (ASDN) including connecting tubule and the CCD.18
A large body of evidence has demonstrated that WNK4
inhibited ROMK channels by facilitating clathrin-dependent
endocytosis.10,19,20 The missense mutations of WNK4 cause
type II pseudohyperaldosteronism, a disease characterized by
hypertension and hyperkalemia.21,22 However, WNK4-induced
inhibition of ROMK channels can be reversed by SGK1, which
phosphorylates WNK4 on serine residues 1169 and 1196.20,23
Thus, the domain containing serine residues 1169 and 1196 is
thought to be an aldosterone-dependent switch domain, which
controls K secretion in ASDN.20 Recently, we demonstrated that
Src-family PTK is involved in suppressing SGK1-mediated
serine phosphorylation of WNK4, thereby enhancing WNK4-
mediated inhibition of ROMK channels.11 However, the
upstream signaling that stimulates Src-family PTK is not
known. This study showed that AngII might be one of
signaling pathways, which stimulate Src-family PTK hereby
modulating the interaction between SGK1 and WNK4.
AngII has been shown to increase Src-family PTK activity
by stimulating nicotinamide adenine dinucleotide phosphate
oxidase (NOX) and increasing superoxide anion genera-
tion in vascular tissue.13,24,25 PKC has been reported to mediate
the stimulatory effect of AngII on NOXII activity in vascular
tissue25 by phosphorylating p47Phox and stimulating the activity
of NOXII.26,27 Phosphorylation of p47Phox is an important step
for the activation of NOXII because phosphorylation of p47Phox
results in the translocation of cytosolic complexes to the
plasma membrane.28 Because superoxide anions stimulate
Src-family PTK,29 PKC can increase Src-family PTK through
increasing generation of superoxide anion. Our previous
study has shown that AT1R has an important role in
generating superoxide anions in the kidney30 and that AngII-
induced inhibition of ROMK channels in the CCD depends
on PKC and NOX.12 Moreover, the role of PKC in mediating
the effect of AngII on Src-family PTK is also supported by the
finding that inhibition of PKC diminished the effect of AngII
on c-Src tyrosine phosphorylation.
A large body of evidence indicates that AngII has an
important role in the regulation renal membrane transport in
the distal nephron segments.12,31–34 AngII has been shown to
stimulate ENaC32 and increase a-ENaC protein abundance.31
Also, AngII has been reported to stimulate Cl absorption in
the CCD of mice through a pendrin-dependent mechan-
ism.33 The role of AngII in the regulation of renal K excretion
is also supported by micropuncture study, in which luminal
AngII inhibits K secretion in the distal nephron from the
distal convoluted tubule to the initial CCD.35 Although AngII
inhibits ROMK channels in the CCD, blocking AT1R may not
affect the net renal K excretion because AngII has opposite
effects on Na and K transport in the CCD. Thus, AngII-
induced stimulation of ENaC would increase the driving
force for K secretion and offset the AngII-induced inhibition
of ROMK channels in the CCD. On the other hand, inhi-
biting renin–AngII is expected to decrease Na transport but
increase apical K channel activity. Moreover, signaling
pathways other than AngII may also be involved in activating
Src-family PTK. For instance, both insulin-like growth factor
and prostaglandin-2-dependent pathway are present in ASDN
and stimulation of insulin-like growth factor and prostaglandin-2
pathway could also activate PKC and PTK36–38 thereby suppress-
ing the interaction of SGK1 and WNK4.
Figure 8 is a scheme illustrating the mechanism by
which the volume-depletion stimulates Na absorption but
suppresses K secretion. Low Na intake abolishes the
inhibitory effect of WNK4 on NaCl cotransporter, thereby
increasing Na absorption in the distal nephron and decreas-
ing the Na delivery to the connecting tubule and the CCD.
Consequently, a decrease in Na delivery in the connecting
tubule and the CCD diminishes the driving force for K
secretion. In addition, AngII pathway should also have a role
Na absorption in DCT
Na Cl Na Na Na K K
WNK4WNK4-P
c-Src
SGK1
CCDDCT
Cl
WNK4-P
SGK1
Volume depletion
Angiotensin II
Aldosterone
Na delivery in CCD
Figure 8 |A cell scheme illustrating the role of angiotensin II
in regulating ROMK channels during the volume depletion.
A dotted line means a diminished effect. Abbreviations: CCD,
cortical collecting duct; DCT, distal convoluted tubule; SGK1,
serum–glucocorticoids-induced kinase 1; WNK4, with-no-lysine
kinase-4.
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in preventing K loss during volume depletion, which is
expected to increase aldosterone secretion and stimulate
Na transport in the ASDN. Both Na restriction and a HK
intake have been shown to increase aldosterone and SGK1.
Aldosterone augments activity of both Na–K–adenosine
triphosphatase and EnaC,39,40 thereby increasing the driving
force for K secretion across the apical membrane. However,
aldosterone alone may not be sufficient to stimulate ROMK
channel activity in the collecting duct because direct infusion
of aldosterone failed to mimic the effect of a HK intake.41
A HK intake is expected not only to stimulate aldosterone
level but also to suppress renin and AngII signaling
pathway.42,43 Consequently, a HK intake stimulates ROMK
channel activity and renal K secretion in ASDN. In contrast,
Na- restriction stimulates both renin–AngII pathway and
aldosterone and SGK1. Thus, an upregulated AngII signaling
may be partially responsible for preventing K loss during
volume depletion. This speculation is supported by the
present finding that AngII inhibits ROMK channels in the
CCD of rats on a low Na diet by PTK-dependent mechanism.
However, we need further experiments to dissect the effects of
PTK on ROMK channels through tyrosine phosphorylation
of ROMK or by suppressing SGK1–WNK4 interaction. But,
this study clearly suggests the role of AngII in inhibiting
K secretion during volume depletion. We conclude that AngII
inhibits ROMK channels in ASDN by two mechanisms:
increasing tyrosine phosphorylation of ROMK channels and
synergizing the WNK4-induced inhibition.
MATERIALS AND METHODS
Cell culture and transient transfection
HEK293T cells were purchased from the American Type Culture
Collection and grown in Dulbecco’s modified Eagle medium
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum (Invitrogen) in 5% CO2 and 95% air at 37 1C. All proteins
including c-Src and ROMK1 were transiently expressed in HEK293
cells and corresponding complementary DNAs were simultaneously
used for the transfection at 50–70% confluence with the complemen-
tary DNA using Lipofectamine 2000 transfection reagent (Invitrogen).
After transfection the cells were incubated for an additional 24 h before
use. The method for treatment of cells with siRNA was similar to those
used for transfecting cells with ROMK and siRNA targeting c-Src was
incorporated into pSuper expression vectors.
Preparation of CCDs
Male Sprague–Dawley rats (5–6 weeks old, o90 g) were used in the
experiments (Taconic Farms, Germantown, NY) and they were fed
with control diet (0.4% Na) or low Na diet (Nao0.0001%) (Harlan
laboratory, WI) for 7 days. Animals were killed by cervical
dislocation and kidneys were removed immediately. The isolated
split-open CCD was placed on a 5 5 mm cover glass coated with
polylysine and then transfered to a chamber (1000ml) mounted on
an inverted Nikon microscope (Nikon, Melville, NY).
Electrophysiology experiment
Within 24 h after transfection, the cells were treated with trypsin-
containing medium (Tryple Ecpresscare, Gibco, Carlsbad, CA) for
10 min to detach the cells. The cell suspension (0.2 ml in volume)
was carefully removed to a 5 5-mm cover glass coated with
polylysin followed by additional incubation for 30 min to allow the
cells to adhere to the cover glass. The cover glass was transferred to a
chamber (1 ml) mounted on the stage of a Nikon inverted
microscope. We carried out the perforated whole-cell patch clamp
experiments at room temperature. The cells were incubated with a
bath solution containing 138 mM KCl, 0.5 mM MgCl2, 1.5 mM CaCl2,
and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH
7.4). Fluorescence signal (an indication of positive transfection) was
detected with an intensified video imaging system including SIT 68
camera. Borosilicate glass (1.7-mm optical density) was used to
make the patch clamp pipettes that were pulled with a Narishege
electrode puller. The pipette had a resistance of 2–4 MO when filled
with 140 mM KCl. The tip of the pipette was filled with pipette
solution containing 140 mM KCl, 2 mM MgCl2, 1 mM CaCl2, 1 mM
EGTA, and 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (pH 7.4). The pipette was then back-filled with amphotericin
B (2 mg/0.1 ml) containing pipette solution. After forming a high
resistance seal (42 GO), the membrane capacitance was monitored
until the whole-cell patch configuration was formed. The cell
membrane capacitance was measured and compensated. The
K currents were measured by an Axon 200A patch clamp amplifier
(Axon, Sunnyvale, CA). The currents were low-pass filtered at 1 KHz
and digitized by an Axon interface (Digidata 1200, Axon, Sunnyvale,
CA) and data were stored in an IBM computer and were analyzed
using the pClamp software system 7 (Axon). The method for
conducting the patch clamp experiments in the split-open CCD has
been described previously.12
Preparation of protein samples
The cells were placed in a lysis buffer containing 150 mM NaCl, 50 mM
Tris HCl, 1% Nonidet P-40 (pH 8.0), and protease inhibitor mixture
(1%) (Sigma, St Louis, MO), was added to the lysis buffer. The tissues
were then homogenized and allowed to sit on ice for an additional
30 min. The sample was subjected to centrifugation at 13,000 rpm for
8 min at 4 1C, and protein concentrations were measured in duplicate
using a Bio-Rad Dc protein assay kit (Bio-Rad, Hercules, CA).
Immunoprecipitation and western blot analysis
The corresponding antibody was added to the protein samples (500mg)
harvested from cell cultures with a ratio of 4mg/1 mg protein. The
mixture was gently rotated at 4 1C overnight, followed by incubation
with 25ml protein A/G plus agarose (Santa Cruz Biotechnology, Santa
Cruz, CA) for an additional 2 h at 4 1C. The tube containing the mixture
was centrifuged at 3000 rpm and the agarose bead pellets were mixed
with 25ml 2 SDS sample buffer containing 4% of SDS, 100 mM of
Tris HCl (pH 6.8), 20% of glycerol, 200 mM of 1,1,1-trichloro-2,
2-bis-(p-chlorophenyl) ethane, and 0.2% of bromophenol blue.
After boiling the sample for 5 min, the proteins were resolved by
electrophoresis on 8% SDS–polyacrylamide gels followed by transferring
them to nitrocellulose membranes. The membranes were blocked with
5% nonfat dry milk in Tris-buffered saline, rinsed, and washed with
0.05% Tween20-Tris-buffered saline buffer. The membranes were washed
3 times with PBS and scanned by Odyssey infrared imaging system
(LI-COR, Odyssey, Lincoln, NE) at a wave length of 680 or 800 nM.
Experimental materials and statistics
The tyrosine phosphorylation antibody (PY20), PKCe and AT1R
antibodies were obtained from Santa Cruz Biotechnology,
whereas c-Src antibody was purchased from Millipore/Upstate
430 Kidney International (2011) 79, 423–431
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(Billerica, MA). Antibodies to GFP and phospho416 c-Src were
purchased from Clonetech (Mountain View, CA) and Sigma,
respectively. All chemicals were from Sigma. The data are presented
as mean±s.e.m. We used a one-way analysis of variance test to
determine the statistical significance. Po0.05 was considered to be
significant.
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